Cargando…
Modulation of the Rat Hepatic Cytochrome P4501A Subfamily Using Biotin Supplementation
Studies have found that biotin favors glucose and lipid metabolism, and medications containing biotin have been developed. Despite the use of biotin as a pharmacological agent, few studies have addressed toxicity aspects including the possible interaction with cytochrome P450 enzyme family. This stu...
Autores principales: | Ronquillo-Sánchez, M. D., Camacho-Carranza, R., Fernandez-Mejia, C., Hernández-Ojeda, S., Elinos-Baez, M., Espinosa-Aguirre, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745937/ https://www.ncbi.nlm.nih.gov/pubmed/23984390 http://dx.doi.org/10.1155/2013/627907 |
Ejemplares similares
-
Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?
por: Santes-Palacios, Rebeca, et al.
Publicado: (2016) -
Induction and inhibition of human cytochrome P4501 by oxygenated polycyclic aromatic hydrocarbons
por: Wincent, Emma, et al.
Publicado: (2016) -
Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan
por: Wu, M-T, et al.
Publicado: (2002) -
Dietary Biotin Supplementation Modifies Hepatic Morphology without Changes in Liver Toxicity Markers
por: Riverón-Negrete, Leticia, et al.
Publicado: (2016) -
Axenfeld-Rieger Syndrome Associated with Congenital
Glaucoma and Cytochrome P4501B1 Gene Mutations
por: Tanwar, Mukesh, et al.
Publicado: (2010)